June 17, 2020 / 11:20 PM / 15 days ago

BRIEF-Telix Restarts ZIRCON Phase III Trial Recruitment In EU

June 18 (Reuters) - Telix Pharmaceuticals Ltd:

* RECOMMENCEMENT OF ZIRCON PHASE III TRIAL RECRUITMENT IN EU

* ZIRCON PHASE III TRIAL OF TLX250-CDX RECOMMENCED PATIENT RECRUITMENT AFTER PAUSE TO DUE TO COVID-19

* EXPECTS CLINICAL TRIAL SITES IN AUSTRALIA, CANADA, TURKEY, USA TO BE REACTIVATED BETWEEN NOW AND SEPT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below